# NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
> **NDA214313** · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2021-01-15
## Drug
- **FDA Application Number:** NDA214313
- **Application type:** New Drug Application
- **Brand name:** NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
- **Generic name:** NOREPINEPHRINE BITARTRATE
- **Active ingredients:** NOREPINEPHRINE BITARTRATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BAXTER HLTHCARE CORP
- **Manufacturer:** Baxter Healthcare Corporation
- **First approval:** 2021-01-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214313)
---
*AI Analytics · CC0 1.0*